Biofarm S.A. (BVB:BIO)

Market Cap	670.05M
Revenue (ttm)	286.77M
Net Income (ttm)	74.40M
Shares Out	985.37M
EPS (ttm)	0.08
PE Ratio	9.01
Forward PE	n/a
Dividend	0.03 (4.53%)
Ex-Dividend Date	Aug 18, 2025

Volume	12,791
Average Volume	19,908
Open	0.6720
Previous Close	0.6700
Day's Range	0.6720 - 0.6860
52-Week Range	0.6600 - 0.8300
Beta	0.30
RSI	47.95
Earnings Date	Feb 28, 2025

About Biofarm

Biofarm S.A. engages in the manufacture and sale of medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 399
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.